The institutional appetite for Bitcoin is showing no signs of slowing down—and now it’s not just tech giants and fintech firms leading the charge. In an unexpected twist, companies from completely different sectors are diving into crypto, and the markets are responding.
On May 22, the little-known Swedish health tech company H100 Group AB made waves when it revealed its very first Bitcoin purchase. The result? A massive 37% jump in its share price in a single trading day. That’s a significant reversal for a stock that had been bleeding value for two months.
According to the company’s disclosure, H100 used 5 million Norwegian krone (about $490,830) to acquire 4.39 BTC at an average price of roughly $111,785 per coin. That’s a bold move for a firm whose core business isn’t remotely related to finance or blockchain—it specializes in consumer health tools aimed at people looking for alternatives to conventional medical systems.
The announcement sparked a strong market reaction, with shares climbing to 1.22 Swedish krona ($0.13) on the Nordic Growth Market, according to Bloomberg. That spike helped claw back some of the 46% decline the stock had experienced over the past couple of months.
Bitcoin Meets Biohacking?
CEO Sander Andersen framed the purchase as more than a financial maneuver. In a statement and a follow-up post on X (formerly Twitter), Andersen emphasized how the ethos of Bitcoin—particularly its focus on individual sovereignty—resonates with the company’s vision. H100, after all, aims to empower individuals to take charge of their health rather than rely on reactive, institutional care.
Andersen hinted that this is just the beginning—calling the purchase “Phase 1,” and suggesting more Bitcoin acquisitions may follow. For a company built around health optimization, integrating crypto into its corporate strategy may seem unconventional, but it could be an early signal of a broader trend: the convergence of financial self-sovereignty with personal wellness.
Meanwhile, in China… a 1,000 BTC Shopping Spree
Across the globe, a very different company is also taking the plunge. Jiuzi Holdings, a Chinese electric vehicle retailer listed on the Nasdaq under the ticker JZXN, revealed its own ambitious Bitcoin plan. The firm’s board has greenlit a proposal to accumulate 1,000 BTC over the next 12 months, using a combination of newly issued stock and direct cash purchases.
While Jiuzi didn’t see the explosive rally that H100 enjoyed, its shares still closed 7.3% higher at $3.09 on the same day, based on Google Finance data.
CEO Tao Li acknowledged Bitcoin’s volatility but expressed confidence in the asset’s long-term benefits. He sees this strategy as a way to bolster Jiuzi’s balance sheet, increase resilience against economic shocks, and even enhance profitability.
A Growing Corporate Trend
What’s most notable here is the growing normalization of Bitcoin as a strategic corporate treasury asset—and not just by the MicroStrategys and Teslas of the world. According to data from BitcoinTreasuries.NET, over 109 publicly traded companies are now holding Bitcoin on their books.
These latest entries from the health tech and EV sectors underscore that Bitcoin’s appeal is becoming more sector-agnostic. Whether it’s a company trying to future-proof its balance sheet or align with the decentralized values of a growing user base, BTC is no longer seen as a fringe experiment—it’s being viewed as a legitimate financial instrument.
Final Thoughts
The moves by H100 and Jiuzi signal a broader shift in how diverse industries are thinking about Bitcoin. It’s not just about speculation anymore—it’s about values, risk management, and even brand alignment.
As Bitcoin continues to hold above the $110,000 mark, expect more unexpected players to join the fold. Because whether you’re selling biohacking tools or electric cars, Bitcoin’s magnetic pull is growing too powerful to ignore.
